カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の粉末止血剤市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Powder Hemostatic Agent Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO18331）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO18331
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医療機器
■ ページ数：95
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の粉末止血剤市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

粉末止血剤市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の粉末止血剤の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

粉末止血剤市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・吸収性止血剤、非吸収性止血剤

用途別セグメントは次のように区分されます。
・病院、診療所、在宅医療

世界の粉末止血剤市場の主要な市場プレーヤーは以下のとおりです。
・Johnson & Johnson（Ethicon）、Celox Medical、Amed Therapeutics、Cryolife、BioCer Entwicklungs-GmbH、Yunnan Baiyao、HHAO TECHNOLOGY

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、粉末止血剤製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な粉末止血剤メーカーの企業概要、2019年～2022年までの粉末止血剤の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な粉末止血剤メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別粉末止血剤の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの粉末止血剤の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での粉末止血剤市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および粉末止血剤の産業チェーンを掲載しています。
・第13、14、15章では、粉末止血剤の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 粉末止血剤の概要
- 種類別分析（2017年vs2021年vs2028年）：吸収性止血剤、非吸収性止血剤
- 用途別分析（2017年vs2021年vs2028年）：病院、診療所、在宅医療
- 世界の粉末止血剤市場規模・予測
- 世界の粉末止血剤生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Johnson & Johnson（Ethicon）、Celox Medical、Amed Therapeutics、Cryolife、BioCer Entwicklungs-GmbH、Yunnan Baiyao、HHAO TECHNOLOGY
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：吸収性止血剤、非吸収性止血剤
・用途別分析2017年-2028年：病院、診療所、在宅医療
・粉末止血剤の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・粉末止血剤のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・粉末止血剤のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・粉末止血剤の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・粉末止血剤の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Powder Hemostatic Agent market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Powder Hemostatic Agent market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals accounting for % of the Powder Hemostatic Agent global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Absorbable Hemostatic Agent segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Powder Hemostatic Agent include Johnson & Johnson（Ethicon）, Celox Medical, Amed Therapeutics, Cryolife, and BioCer Entwicklungs-GmbH, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Powder Hemostatic Agent market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Absorbable Hemostatic Agent
Not Absorbable Hemostatic Agent
Market segment by Application can be divided into
Hospitals
Clinics
Home Care
The key market players for global Powder Hemostatic Agent market are listed below:
Johnson & Johnson（Ethicon）
Celox Medical
Amed Therapeutics
Cryolife
BioCer Entwicklungs-GmbH
Yunnan Baiyao
HHAO TECHNOLOGY
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Powder Hemostatic Agent product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Powder Hemostatic Agent, with price, sales, revenue and global market share of Powder Hemostatic Agent from 2019 to 2022.
Chapter 3, the Powder Hemostatic Agent competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Powder Hemostatic Agent breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Powder Hemostatic Agent market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Powder Hemostatic Agent.
Chapter 13, 14, and 15, to describe Powder Hemostatic Agent sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Powder Hemostatic Agent Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Powder Hemostatic Agent Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Absorbable Hemostatic Agent
1.2.3 Not Absorbable Hemostatic Agent
1.3 Market Analysis by Application
1.3.1 Overview: Global Powder Hemostatic Agent Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Home Care
1.4 Global Powder Hemostatic Agent Market Size & Forecast
1.4.1 Global Powder Hemostatic Agent Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Powder Hemostatic Agent Sales in Volume (2017-2028)
1.4.3 Global Powder Hemostatic Agent Price (2017-2028)
1.5 Global Powder Hemostatic Agent Production Capacity Analysis
1.5.1 Global Powder Hemostatic Agent Total Production Capacity (2017-2028)
1.5.2 Global Powder Hemostatic Agent Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Powder Hemostatic Agent Market Drivers
1.6.2 Powder Hemostatic Agent Market Restraints
1.6.3 Powder Hemostatic Agent Trends Analysis
2 Manufacturers Profiles
2.1 Johnson & Johnson（Ethicon）
2.1.1 Johnson & Johnson（Ethicon） Details
2.1.2 Johnson & Johnson（Ethicon） Major Business
2.1.3 Johnson & Johnson（Ethicon） Powder Hemostatic Agent Product and Services
2.1.4 Johnson & Johnson（Ethicon） Powder Hemostatic Agent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Celox Medical
2.2.1 Celox Medical Details
2.2.2 Celox Medical Major Business
2.2.3 Celox Medical Powder Hemostatic Agent Product and Services
2.2.4 Celox Medical Powder Hemostatic Agent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Amed Therapeutics
2.3.1 Amed Therapeutics Details
2.3.2 Amed Therapeutics Major Business
2.3.3 Amed Therapeutics Powder Hemostatic Agent Product and Services
2.3.4 Amed Therapeutics Powder Hemostatic Agent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Cryolife
2.4.1 Cryolife Details
2.4.2 Cryolife Major Business
2.4.3 Cryolife Powder Hemostatic Agent Product and Services
2.4.4 Cryolife Powder Hemostatic Agent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 BioCer Entwicklungs-GmbH
2.5.1 BioCer Entwicklungs-GmbH Details
2.5.2 BioCer Entwicklungs-GmbH Major Business
2.5.3 BioCer Entwicklungs-GmbH Powder Hemostatic Agent Product and Services
2.5.4 BioCer Entwicklungs-GmbH Powder Hemostatic Agent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Yunnan Baiyao
2.6.1 Yunnan Baiyao Details
2.6.2 Yunnan Baiyao Major Business
2.6.3 Yunnan Baiyao Powder Hemostatic Agent Product and Services
2.6.4 Yunnan Baiyao Powder Hemostatic Agent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 HHAO TECHNOLOGY
2.7.1 HHAO TECHNOLOGY Details
2.7.2 HHAO TECHNOLOGY Major Business
2.7.3 HHAO TECHNOLOGY Powder Hemostatic Agent Product and Services
2.7.4 HHAO TECHNOLOGY Powder Hemostatic Agent Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Powder Hemostatic Agent Breakdown Data by Manufacturer
3.1 Global Powder Hemostatic Agent Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Powder Hemostatic Agent Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Powder Hemostatic Agent
3.4 Market Concentration Rate
3.4.1 Top 3 Powder Hemostatic Agent Manufacturer Market Share in 2021
3.4.2 Top 6 Powder Hemostatic Agent Manufacturer Market Share in 2021
3.5 Global Powder Hemostatic Agent Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Powder Hemostatic Agent Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Powder Hemostatic Agent Market Size by Region
4.1.1 Global Powder Hemostatic Agent Sales in Volume by Region (2017-2028)
4.1.2 Global Powder Hemostatic Agent Revenue by Region (2017-2028)
4.2 North America Powder Hemostatic Agent Revenue (2017-2028)
4.3 Europe Powder Hemostatic Agent Revenue (2017-2028)
4.4 Asia-Pacific Powder Hemostatic Agent Revenue (2017-2028)
4.5 South America Powder Hemostatic Agent Revenue (2017-2028)
4.6 Middle East and Africa Powder Hemostatic Agent Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Powder Hemostatic Agent Sales in Volume by Type (2017-2028)
5.2 Global Powder Hemostatic Agent Revenue by Type (2017-2028)
5.3 Global Powder Hemostatic Agent Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Powder Hemostatic Agent Sales in Volume by Application (2017-2028)
6.2 Global Powder Hemostatic Agent Revenue by Application (2017-2028)
6.3 Global Powder Hemostatic Agent Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Powder Hemostatic Agent Sales by Type (2017-2028)
7.2 North America Powder Hemostatic Agent Sales by Application (2017-2028)
7.3 North America Powder Hemostatic Agent Market Size by Country
7.3.1 North America Powder Hemostatic Agent Sales in Volume by Country (2017-2028)
7.3.2 North America Powder Hemostatic Agent Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Powder Hemostatic Agent Sales by Type (2017-2028)
8.2 Europe Powder Hemostatic Agent Sales by Application (2017-2028)
8.3 Europe Powder Hemostatic Agent Market Size by Country
8.3.1 Europe Powder Hemostatic Agent Sales in Volume by Country (2017-2028)
8.3.2 Europe Powder Hemostatic Agent Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Powder Hemostatic Agent Sales by Type (2017-2028)
9.2 Asia-Pacific Powder Hemostatic Agent Sales by Application (2017-2028)
9.3 Asia-Pacific Powder Hemostatic Agent Market Size by Region
9.3.1 Asia-Pacific Powder Hemostatic Agent Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Powder Hemostatic Agent Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Powder Hemostatic Agent Sales by Type (2017-2028)
10.2 South America Powder Hemostatic Agent Sales by Application (2017-2028)
10.3 South America Powder Hemostatic Agent Market Size by Country
10.3.1 South America Powder Hemostatic Agent Sales in Volume by Country (2017-2028)
10.3.2 South America Powder Hemostatic Agent Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Powder Hemostatic Agent Sales by Type (2017-2028)
11.2 Middle East & Africa Powder Hemostatic Agent Sales by Application (2017-2028)
11.3 Middle East & Africa Powder Hemostatic Agent Market Size by Country
11.3.1 Middle East & Africa Powder Hemostatic Agent Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Powder Hemostatic Agent Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Powder Hemostatic Agent and Key Manufacturers
12.2 Manufacturing Costs Percentage of Powder Hemostatic Agent
12.3 Powder Hemostatic Agent Production Process
12.4 Powder Hemostatic Agent Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Powder Hemostatic Agent Typical Distributors
13.3 Powder Hemostatic Agent Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Powder Hemostatic Agent Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Powder Hemostatic Agent Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Johnson & Johnson（Ethicon） Basic Information, Manufacturing Base and Competitors
Table 4. Johnson & Johnson（Ethicon） Major Business
Table 5. Johnson & Johnson（Ethicon） Powder Hemostatic Agent Product and Services
Table 6. Johnson & Johnson（Ethicon） Powder Hemostatic Agent Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Celox Medical Basic Information, Manufacturing Base and Competitors
Table 8. Celox Medical Major Business
Table 9. Celox Medical Powder Hemostatic Agent Product and Services
Table 10. Celox Medical Powder Hemostatic Agent Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Amed Therapeutics Basic Information, Manufacturing Base and Competitors
Table 12. Amed Therapeutics Major Business
Table 13. Amed Therapeutics Powder Hemostatic Agent Product and Services
Table 14. Amed Therapeutics Powder Hemostatic Agent Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Cryolife Basic Information, Manufacturing Base and Competitors
Table 16. Cryolife Major Business
Table 17. Cryolife Powder Hemostatic Agent Product and Services
Table 18. Cryolife Powder Hemostatic Agent Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. BioCer Entwicklungs-GmbH Basic Information, Manufacturing Base and Competitors
Table 20. BioCer Entwicklungs-GmbH Major Business
Table 21. BioCer Entwicklungs-GmbH Powder Hemostatic Agent Product and Services
Table 22. BioCer Entwicklungs-GmbH Powder Hemostatic Agent Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Yunnan Baiyao Basic Information, Manufacturing Base and Competitors
Table 24. Yunnan Baiyao Major Business
Table 25. Yunnan Baiyao Powder Hemostatic Agent Product and Services
Table 26. Yunnan Baiyao Powder Hemostatic Agent Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. HHAO TECHNOLOGY Basic Information, Manufacturing Base and Competitors
Table 28. HHAO TECHNOLOGY Major Business
Table 29. HHAO TECHNOLOGY Powder Hemostatic Agent Product and Services
Table 30. HHAO TECHNOLOGY Powder Hemostatic Agent Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Global Powder Hemostatic Agent Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 32. Global Powder Hemostatic Agent Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 33. Market Position of Manufacturers in Powder Hemostatic Agent, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 34. Global Powder Hemostatic Agent Production Capacity by Company, (K Units): 2020 VS 2021
Table 35. Head Office and Powder Hemostatic Agent Production Site of Key Manufacturer
Table 36. Powder Hemostatic Agent New Entrant and Capacity Expansion Plans
Table 37. Powder Hemostatic Agent Mergers & Acquisitions in the Past Five Years
Table 38. Global Powder Hemostatic Agent Sales by Region (2017-2022) & (K Units)
Table 39. Global Powder Hemostatic Agent Sales by Region (2023-2028) & (K Units)
Table 40. Global Powder Hemostatic Agent Revenue by Region (2017-2022) & (USD Million)
Table 41. Global Powder Hemostatic Agent Revenue by Region (2023-2028) & (USD Million)
Table 42. Global Powder Hemostatic Agent Sales by Type (2017-2022) & (K Units)
Table 43. Global Powder Hemostatic Agent Sales by Type (2023-2028) & (K Units)
Table 44. Global Powder Hemostatic Agent Revenue by Type (2017-2022) & (USD Million)
Table 45. Global Powder Hemostatic Agent Revenue by Type (2023-2028) & (USD Million)
Table 46. Global Powder Hemostatic Agent Price by Type (2017-2022) & (USD/Unit)
Table 47. Global Powder Hemostatic Agent Price by Type (2023-2028) & (USD/Unit)
Table 48. Global Powder Hemostatic Agent Sales by Application (2017-2022) & (K Units)
Table 49. Global Powder Hemostatic Agent Sales by Application (2023-2028) & (K Units)
Table 50. Global Powder Hemostatic Agent Revenue by Application (2017-2022) & (USD Million)
Table 51. Global Powder Hemostatic Agent Revenue by Application (2023-2028) & (USD Million)
Table 52. Global Powder Hemostatic Agent Price by Application (2017-2022) & (USD/Unit)
Table 53. Global Powder Hemostatic Agent Price by Application (2023-2028) & (USD/Unit)
Table 54. North America Powder Hemostatic Agent Sales by Country (2017-2022) & (K Units)
Table 55. North America Powder Hemostatic Agent Sales by Country (2023-2028) & (K Units)
Table 56. North America Powder Hemostatic Agent Revenue by Country (2017-2022) & (USD Million)
Table 57. North America Powder Hemostatic Agent Revenue by Country (2023-2028) & (USD Million)
Table 58. North America Powder Hemostatic Agent Sales by Type (2017-2022) & (K Units)
Table 59. North America Powder Hemostatic Agent Sales by Type (2023-2028) & (K Units)
Table 60. North America Powder Hemostatic Agent Sales by Application (2017-2022) & (K Units)
Table 61. North America Powder Hemostatic Agent Sales by Application (2023-2028) & (K Units)
Table 62. Europe Powder Hemostatic Agent Sales by Country (2017-2022) & (K Units)
Table 63. Europe Powder Hemostatic Agent Sales by Country (2023-2028) & (K Units)
Table 64. Europe Powder Hemostatic Agent Revenue by Country (2017-2022) & (USD Million)
Table 65. Europe Powder Hemostatic Agent Revenue by Country (2023-2028) & (USD Million)
Table 66. Europe Powder Hemostatic Agent Sales by Type (2017-2022) & (K Units)
Table 67. Europe Powder Hemostatic Agent Sales by Type (2023-2028) & (K Units)
Table 68. Europe Powder Hemostatic Agent Sales by Application (2017-2022) & (K Units)
Table 69. Europe Powder Hemostatic Agent Sales by Application (2023-2028) & (K Units)
Table 70. Asia-Pacific Powder Hemostatic Agent Sales by Region (2017-2022) & (K Units)
Table 71. Asia-Pacific Powder Hemostatic Agent Sales by Region (2023-2028) & (K Units)
Table 72. Asia-Pacific Powder Hemostatic Agent Revenue by Region (2017-2022) & (USD Million)
Table 73. Asia-Pacific Powder Hemostatic Agent Revenue by Region (2023-2028) & (USD Million)
Table 74. Asia-Pacific Powder Hemostatic Agent Sales by Type (2017-2022) & (K Units)
Table 75. Asia-Pacific Powder Hemostatic Agent Sales by Type (2023-2028) & (K Units)
Table 76. Asia-Pacific Powder Hemostatic Agent Sales by Application (2017-2022) & (K Units)
Table 77. Asia-Pacific Powder Hemostatic Agent Sales by Application (2023-2028) & (K Units)
Table 78. South America Powder Hemostatic Agent Sales by Country (2017-2022) & (K Units)
Table 79. South America Powder Hemostatic Agent Sales by Country (2023-2028) & (K Units)
Table 80. South America Powder Hemostatic Agent Revenue by Country (2017-2022) & (USD Million)
Table 81. South America Powder Hemostatic Agent Revenue by Country (2023-2028) & (USD Million)
Table 82. South America Powder Hemostatic Agent Sales by Type (2017-2022) & (K Units)
Table 83. South America Powder Hemostatic Agent Sales by Type (2023-2028) & (K Units)
Table 84. South America Powder Hemostatic Agent Sales by Application (2017-2022) & (K Units)
Table 85. South America Powder Hemostatic Agent Sales by Application (2023-2028) & (K Units)
Table 86. Middle East & Africa Powder Hemostatic Agent Sales by Region (2017-2022) & (K Units)
Table 87. Middle East & Africa Powder Hemostatic Agent Sales by Region (2023-2028) & (K Units)
Table 88. Middle East & Africa Powder Hemostatic Agent Revenue by Region (2017-2022) & (USD Million)
Table 89. Middle East & Africa Powder Hemostatic Agent Revenue by Region (2023-2028) & (USD Million)
Table 90. Middle East & Africa Powder Hemostatic Agent Sales by Type (2017-2022) & (K Units)
Table 91. Middle East & Africa Powder Hemostatic Agent Sales by Type (2023-2028) & (K Units)
Table 92. Middle East & Africa Powder Hemostatic Agent Sales by Application (2017-2022) & (K Units)
Table 93. Middle East & Africa Powder Hemostatic Agent Sales by Application (2023-2028) & (K Units)
Table 94. Powder Hemostatic Agent Raw Material
Table 95. Key Manufacturers of Powder Hemostatic Agent Raw Materials
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Powder Hemostatic Agent Typical Distributors
Table 99. Powder Hemostatic Agent Typical Customers
List of Figures
Figure 1. Powder Hemostatic Agent Picture
Figure 2. Global Powder Hemostatic Agent Revenue Market Share by Type in 2021
Figure 3. Absorbable Hemostatic Agent
Figure 4. Not Absorbable Hemostatic Agent
Figure 5. Global Powder Hemostatic Agent Revenue Market Share by Application in 2021
Figure 6. Hospitals
Figure 7. Clinics
Figure 8. Home Care
Figure 9. Global Powder Hemostatic Agent Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Powder Hemostatic Agent Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Powder Hemostatic Agent Sales (2017-2028) & (K Units)
Figure 12. Global Powder Hemostatic Agent Price (2017-2028) & (USD/Unit)
Figure 13. Global Powder Hemostatic Agent Production Capacity (2017-2028) & (K Units)
Figure 14. Global Powder Hemostatic Agent Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Powder Hemostatic Agent Market Drivers
Figure 16. Powder Hemostatic Agent Market Restraints
Figure 17. Powder Hemostatic Agent Market Trends
Figure 18. Global Powder Hemostatic Agent Sales Market Share by Manufacturer in 2021
Figure 19. Global Powder Hemostatic Agent Revenue Market Share by Manufacturer in 2021
Figure 20. Powder Hemostatic Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Powder Hemostatic Agent Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Powder Hemostatic Agent Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Powder Hemostatic Agent Sales Market Share by Region (2017-2028)
Figure 24. Global Powder Hemostatic Agent Revenue Market Share by Region (2017-2028)
Figure 25. North America Powder Hemostatic Agent Revenue (2017-2028) & (USD Million)
Figure 26. Europe Powder Hemostatic Agent Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Powder Hemostatic Agent Revenue (2017-2028) & (USD Million)
Figure 28. South America Powder Hemostatic Agent Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Powder Hemostatic Agent Revenue (2017-2028) & (USD Million)
Figure 30. Global Powder Hemostatic Agent Sales Market Share by Type (2017-2028)
Figure 31. Global Powder Hemostatic Agent Revenue Market Share by Type (2017-2028)
Figure 32. Global Powder Hemostatic Agent Price by Type (2017-2028) & (USD/Unit)
Figure 33. Global Powder Hemostatic Agent Sales Market Share by Application (2017-2028)
Figure 34. Global Powder Hemostatic Agent Revenue Market Share by Application (2017-2028)
Figure 35. Global Powder Hemostatic Agent Price by Application (2017-2028) & (USD/Unit)
Figure 36. North America Powder Hemostatic Agent Sales Market Share by Type (2017-2028)
Figure 37. North America Powder Hemostatic Agent Sales Market Share by Application (2017-2028)
Figure 38. North America Powder Hemostatic Agent Sales Market Share by Country (2017-2028)
Figure 39. North America Powder Hemostatic Agent Revenue Market Share by Country (2017-2028)
Figure 40. United States Powder Hemostatic Agent Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Powder Hemostatic Agent Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Powder Hemostatic Agent Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Powder Hemostatic Agent Sales Market Share by Type (2017-2028)
Figure 44. Europe Powder Hemostatic Agent Sales Market Share by Application (2017-2028)
Figure 45. Europe Powder Hemostatic Agent Sales Market Share by Country (2017-2028)
Figure 46. Europe Powder Hemostatic Agent Revenue Market Share by Country (2017-2028)
Figure 47. Germany Powder Hemostatic Agent Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Powder Hemostatic Agent Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Powder Hemostatic Agent Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Powder Hemostatic Agent Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Powder Hemostatic Agent Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Powder Hemostatic Agent Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Powder Hemostatic Agent Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Powder Hemostatic Agent Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Powder Hemostatic Agent Revenue Market Share by Region (2017-2028)
Figure 56. China Powder Hemostatic Agent Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Powder Hemostatic Agent Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Powder Hemostatic Agent Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Powder Hemostatic Agent Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Powder Hemostatic Agent Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Powder Hemostatic Agent Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Powder Hemostatic Agent Sales Market Share by Type (2017-2028)
Figure 63. South America Powder Hemostatic Agent Sales Market Share by Application (2017-2028)
Figure 64. South America Powder Hemostatic Agent Sales Market Share by Country (2017-2028)
Figure 65. South America Powder Hemostatic Agent Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Powder Hemostatic Agent Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Powder Hemostatic Agent Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Powder Hemostatic Agent Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Powder Hemostatic Agent Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Powder Hemostatic Agent Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Powder Hemostatic Agent Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Powder Hemostatic Agent Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Powder Hemostatic Agent Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Powder Hemostatic Agent Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Powder Hemostatic Agent Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Powder Hemostatic Agent in 2021
Figure 77. Manufacturing Process Analysis of Powder Hemostatic Agent
Figure 78. Powder Hemostatic Agent Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の吸収性止血剤と包帯市場2022年：市場規模予測（～2028年）
  • 世界の吸収性止血スポンジ市場2022年：市場規模予測（～2028年）
  • 世界の吸収性止血ゼラチンスポンジ市場2022年：市場規模予測（～2028年）
  • 医療用吸収性止血ガーゼの世界市場2023年：単層ガーゼ、多層ガーゼ
  • 世界の眼科用粘弾性剤市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO18331 )"世界の粉末止血剤市場2022年：市場規模予測（～2028年）" (英文：Global Powder Hemostatic Agent Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。